vs

Side-by-side financial comparison of HARTE HANKS INC (HHS) and Orchid Island Capital, Inc. (ORC). Click either name above to swap in a different company.

HARTE HANKS INC is the larger business by last-quarter revenue ($39.9M vs $38.5M, roughly 1.0× Orchid Island Capital, Inc.). Orchid Island Capital, Inc. runs the higher net margin — 268.7% vs 5.5%, a 263.2% gap on every dollar of revenue. On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs -15.4%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs -6.4%).

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.

HHS vs ORC — Head-to-Head

Bigger by revenue
HHS
HHS
1.0× larger
HHS
$39.9M
$38.5M
ORC
Growing faster (revenue YoY)
ORC
ORC
+388.0% gap
ORC
372.6%
-15.4%
HHS
Higher net margin
ORC
ORC
263.2% more per $
ORC
268.7%
5.5%
HHS
Faster 2-yr revenue CAGR
ORC
ORC
Annualised
ORC
301.6%
-6.4%
HHS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HHS
HHS
ORC
ORC
Revenue
$39.9M
$38.5M
Net Profit
$2.2M
$103.4M
Gross Margin
Operating Margin
-0.3%
Net Margin
5.5%
268.7%
Revenue YoY
-15.4%
372.6%
Net Profit YoY
1764.9%
EPS (diluted)
$0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HHS
HHS
ORC
ORC
Q4 25
$39.9M
$38.5M
Q3 25
$39.5M
$26.9M
Q2 25
$38.6M
$23.2M
Q1 25
$41.6M
$19.7M
Q4 24
$47.1M
Q3 24
$47.6M
$340.0K
Q2 24
$45.0M
$-697.0K
Q1 24
$45.4M
$-2.5M
Net Profit
HHS
HHS
ORC
ORC
Q4 25
$2.2M
$103.4M
Q3 25
$-2.3M
$72.1M
Q2 25
$-335.0K
$-33.6M
Q1 25
$-392.0K
$17.1M
Q4 24
Q3 24
$142.0K
$17.3M
Q2 24
$-27.8M
$-5.0M
Q1 24
$-171.0K
$19.8M
Operating Margin
HHS
HHS
ORC
ORC
Q4 25
-0.3%
Q3 25
1.3%
Q2 25
0.1%
Q1 25
-0.1%
Q4 24
-3.3%
Q3 24
4.0%
Q2 24
3.0%
Q1 24
0.8%
Net Margin
HHS
HHS
ORC
ORC
Q4 25
5.5%
268.7%
Q3 25
-5.8%
267.8%
Q2 25
-0.9%
-145.0%
Q1 25
-0.9%
86.9%
Q4 24
Q3 24
0.3%
5094.1%
Q2 24
-61.8%
714.3%
Q1 24
-0.4%
-794.2%
EPS (diluted)
HHS
HHS
ORC
ORC
Q4 25
$0.30
Q3 25
$-0.31
Q2 25
$-0.05
Q1 25
$-0.05
Q4 24
$-0.31
Q3 24
$0.02
Q2 24
$-3.84
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HHS
HHS
ORC
ORC
Cash + ST InvestmentsLiquidity on hand
$5.6M
$665.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$20.5M
$1.4B
Total Assets
$91.8M
$11.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HHS
HHS
ORC
ORC
Q4 25
$5.6M
$665.9M
Q3 25
$6.5M
$583.9M
Q2 25
$4.8M
$440.8M
Q1 25
$9.0M
$396.4M
Q4 24
$9.8M
Q3 24
$5.9M
$322.1M
Q2 24
$11.0M
$241.0M
Q1 24
$11.5M
$190.4M
Stockholders' Equity
HHS
HHS
ORC
ORC
Q4 25
$20.5M
$1.4B
Q3 25
$19.9M
$1.1B
Q2 25
$22.2M
$912.0M
Q1 25
$21.4M
$855.9M
Q4 24
$21.7M
Q3 24
$21.0M
$656.0M
Q2 24
$20.6M
$555.9M
Q1 24
$20.0M
$481.6M
Total Assets
HHS
HHS
ORC
ORC
Q4 25
$91.8M
$11.7B
Q3 25
$92.7M
$9.1B
Q2 25
$95.0M
$7.6B
Q1 25
$100.6M
$7.3B
Q4 24
$101.8M
Q3 24
$108.1M
$5.9B
Q2 24
$109.7M
$4.9B
Q1 24
$113.4M
$4.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HHS
HHS
ORC
ORC
Operating Cash FlowLast quarter
$737.0K
$120.4M
Free Cash FlowOCF − Capex
$-686.0K
FCF MarginFCF / Revenue
-1.7%
Capex IntensityCapex / Revenue
3.6%
Cash ConversionOCF / Net Profit
0.33×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$-4.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HHS
HHS
ORC
ORC
Q4 25
$737.0K
$120.4M
Q3 25
$3.2M
$28.0M
Q2 25
$-4.8M
$18.4M
Q1 25
$-818.0K
$25.8M
Q4 24
$4.0M
Q3 24
$-2.9M
$-14.8M
Q2 24
$1.6M
$19.3M
Q1 24
$-5.7M
$45.0M
Free Cash Flow
HHS
HHS
ORC
ORC
Q4 25
$-686.0K
Q3 25
$2.2M
Q2 25
$-5.1M
Q1 25
$-923.0K
Q4 24
$3.4M
Q3 24
$-4.9M
Q2 24
$926.0K
Q1 24
$-6.2M
FCF Margin
HHS
HHS
ORC
ORC
Q4 25
-1.7%
Q3 25
5.5%
Q2 25
-13.1%
Q1 25
-2.2%
Q4 24
7.3%
Q3 24
-10.2%
Q2 24
2.1%
Q1 24
-13.7%
Capex Intensity
HHS
HHS
ORC
ORC
Q4 25
3.6%
Q3 25
2.5%
Q2 25
0.6%
Q1 25
0.3%
Q4 24
1.3%
Q3 24
4.0%
Q2 24
1.5%
Q1 24
1.2%
Cash Conversion
HHS
HHS
ORC
ORC
Q4 25
0.33×
1.16×
Q3 25
0.39×
Q2 25
Q1 25
1.51×
Q4 24
Q3 24
-20.76×
-0.86×
Q2 24
Q1 24
2.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

ORC
ORC

Segment breakdown not available.

Related Comparisons